WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 1.2% of their position (2K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $3.1K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/30/2023ACC: 0001213900-23-091665
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+2K
Net shares
Net buyer
$3.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
2K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1K
Price / share
$1.57
Trade value
$1.57K
% of position
0.6%
11/29/2023
165.12K→166.12K
Common Stock
Direct
Shares
+1K
Price / share
$1.53
Trade value
$1.53K
% of position
0.6%
11/30/2023
166.12K→167.12K
Total
Net shares
+2K
Net value
$3.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/29/2023 | P · Purchase | +1K | $1.57 | $1.57K | 0.6% | 165.12K | 166.12K |
| Common Stock Direct | 11/30/2023 | P · Purchase | +1K | $1.53 | $1.53K | 0.6% | 166.12K | 167.12K |
| Total | +2K | $3.10K | ||||||
Derivative Transactions0
No derivative transactions reported